politics

Leucovorin endorsement for autism by FDA falls through. What’s next?

In September, officials touted leucovorin as a potential treatment for thousands of children with autism. Now the FDA is walking back from that claim as the drug is approved for a rare genetic condition, not autism. CNN’s Meg Tirrell reports.

Leucovorin endorsement for autism by FDA falls through. What’s next?

TL;DR

  • FDA retracts leucovorin endorsement for autism, approving it for a rare genetic condition.
  • Timothée Chalamet faces backlash for remarks about ballet and opera.
  • Kai Trump criticized for a video showing her luxury shopping with Secret Service.
  • A man donates part of his brain for research into cancer and Alzheimer's.
  • The social media trend 'Chinamaxxing' and its cultural implications are explained.
  • An update on the internet-famous monkey, Punch.
  • The 'JFK Jr. effect' influences men's fashion in New York City.
  • Live Nation and Ticketmaster settle a lawsuit with the Department of Justice over monopoly accusations.